Bio-Medical Applictions Of Tennessee Inc is a medicare approved dialysis facility center in Memphis, Tennessee and it has 19 dialysis stations. It is located in Shelby county at 4601 Quince Road, Memphis, TN, 38117. You can reach out to the office of Bio-Medical Applictions Of Tennessee Inc at (901) 767-0223. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Bio-Medical Applictions Of Tennessee Inc has the following ownership type - Profit. It was first certified by medicare in January, 2016. The medicare id for this facility is 442731 and it accepts patients under medicare ESRD program.
| Name | Bio-Medical Applictions Of Tennessee Inc |
|---|---|
| Location | 4601 Quince Road, Memphis, Tennessee |
| No. of Dialysis Stations | 19 |
| Medicare ID | 442731 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | No |
| NPI Number | 1639591951 |
| Organization Name | Fresenius Medical Care Central Memphis |
| Doing Business As | Bio-medical Applications Of Tennessee, Inc. |
| Address | 4601 Quince Rd Memphis, Tennessee, 38117 |
| Phone Number | (901) 767-0223 |
| Dialysis patients with Hemoglobin data | 20 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 25 |
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 33 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 222 |
| Percentage of adult patients getting regular hemodialysis at the center | 99 |
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Bio-Medical Applictions Of Tennessee Inc with elevated calcium levels.
| Patients with hypercalcemia | 38 |
| Hypercalcemia patient months | 243 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 2 |
| Patients with Serumphosphor | 40 |
| Patients with Serumphosphor less than 3.5 mg/dL | 6 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 26 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 35 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 20 |
| Patients with Serumphosphor greater than 7 mg/dL | 12 |
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 39 |
| Patient months included in arterial venous fistula and catheter summaries | 235 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 78 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 12 |
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 20 |
| Hospitalization Rate in facility | 71.2 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 356.6 |
| Hospitalization Rate: Lower Confidence Limit | 16.1 |
The rate of readmission show you whether patients who were being treated regularly at Bio-Medical Applictions Of Tennessee Inc were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 8.8 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 39.3 |
| Readmission Rate: Lower Confidence Limit | .3 |
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Bio-Medical Applictions Of Tennessee Inc's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 18 |
The rate of mortality show you whether patients who were being treated regularly at Bio-Medical Applictions Of Tennessee Inc lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 24 |
Memphis Central Dialysis Location: 889 Dr. M. L. King Jr. Ave, Memphis, Tennessee, 38126 Phone: (901) 525-1719 |
Memphis East Dialysis Location: 50 Humphreys Blvd Ste 42, Memphis, Tennessee, 38120 Phone: (901) 747-2316 |